EAST-AFNET 4:早期节律控制通过恢复窦性心律改善房颤结局
该研究基于EAST-AFNET 4试验数据,在12个月随访时识别早期节律控制(ERC)效果的潜在中介因素。12个月时未恢复窦性心律的患者,ERC未减少未来心血管结局(HR 0.94,95%CI 0.65-1.67)。结论认为ERC的有效性由12个月时窦性心律的存在所中介,临床应追求快速且持续恢复窦性心律。
要点
- 12个月时窦性心律解释早期节律控制81%的治疗效果
- 未恢复窦性心律者,早期节律控制未减少未来心血管结局
- 房颤复发仅解释31%、12个月收缩压仅解释10%的治疗效果
核心结论
- 早期节律控制的有效性由12个月时窦性心律的存在所中介。
- 临床实施早期节律控制应追求快速且持续恢复窦性心律。
研究设计与样本
- 基于EAST-AFNET 4试验数据集的分析。
- 在总研究人群中于12个月随访时识别ERC效果的潜在中介因素,并采用指数模型中的四向分解法进一步探究治疗效果。
- 在后续随访(4.1年)中评估未来主要结局事件。
主要发现
- 12个月时窦性心律解释了ERC相对于常规治疗在后续随访(4.1年)中81%的治疗效果。
- 12个月时未处于窦性心律的患者,ERC未减少未来心血管结局(HR 0.94,95%CI 0.65-1.67)。
- 模型中纳入房颤复发仅解释31%的治疗效果,纳入12个月时收缩压仅解释10%。
- 接受房颤消融与未接受房颤消融的患者结局无差异。
临床怎么用
- 对近期诊断房颤且合并心血管合并症的患者,实施早期节律控制应以快速且持续恢复窦性心律为目标。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: A strategy of systematic, early rhythm control (ERC) improves cardiovascular outcomes in patients with atrial fibrillation (AF). It is not known how this outcome-reducing effect is mediated. METHODS AND RESULTS: Using the Early treatment of Atrial Fibrillation for Stroke prevention Trial (EAST-AFNET 4) data set, potential mediators of the effect of ERC were identified in the total study population at 12-month follow up and further interrogated by use of a four-way decomposition of the treatment effect in an exponential model predicting future primary outcome events. Fourteen potential mediators of ERC were identified at the 12-month visit. Of these, sinus rhythm at 12 months explained 81% of the treatment effect of ERC compared with usual care during the remainder of follow up (4.1 years). In patients not in sinus rhythm at 12 months, ERC did not reduce future cardiovascular outcomes (hazard ratio 0.94, 95% confidence interval 0.65-1.67). Inclusion of AF recurrence in the model only explained 31% of the treatment effect, and inclusion of systolic blood pressure at 12 months only 10%. There was no difference in outcomes in patients who underwent AF ablation compared with those who did not undergo AF ablation. CONCLUSION: The effectiveness of early rhythm control is mediated by the presence of sinus rhythm at 12 months in the EAST-AFNET 4 trial. Clinicians implementing ERC should aim for rapid and sustained restoration of sinus rhythm in patients with recently diagnosed AF and cardiovascular comorbidities.
引用
- Eckardt, Sehner, Suling, et al. Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial. Eur Heart J. 2022. PMID: 36036648. doi:10.1093/eurheartj/ehac471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。